血小板 RNA-Seq は,大動脈内膜の厚さに関連した遺伝子を明らかにする:横断的な研究
Zhanfei Tan1, Fan Guo2,3, Jiaming Gao2,3
1Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
TH open : companion journal to thrombosis and haemostasis
|August 27, 2025
まとめ
この研究では,動脈硬化症の進行に関連した4つの主要な血小板遺伝子 (ITGA2B,TGFB1,PF4,GP9) が特定されました. これらの遺伝子は,動脈硬化症のリスクを診断し予測するための新しいバイオマーカーとして潜在性を示しています.
科学分野:
- 心血管研究
- 分子生物学
- バイオマーカーの発見
背景:
- 動脈硬化 (AS) のリスクは血小板の特徴と関連しているが,その正確な役割は不明である.
- 血小板の機能を理解することはASの病原化と診断に不可欠です.
研究 の 目的:
- 血小板遺伝子発現の違いを特定する
- ASの診断とリスク評価のための新しい血小板由来バイオマーカーを発見する.
主な方法:
- AS患者と健康な対照群を比較した横断研究 (N).
- ASの定義のためにインティマメディアの厚さ (IMT) を測定するために使用される動脈超音波.
- 血小板RNA配列決定 (RNA-seq) は,抽出された血小板で実施された.
主要な成果:
- ダウンレギュレーションとアップレギュレーションを含む,784の異なる発現遺伝子を特定した.
- 遺伝子オントロジー分析では 血液凝固経路の有意な強化が示された.
- 重み付けの相関ネットワーク分析では,IMTと相関する4つのハブ遺伝子 (ITGA2B,TGFB1,PF4,GP9) が特定されました.
結論:
- ITGA2B,TGFB1,PF4,GP9の値上昇は,IMT増加と中程度の相関関係を示した.
- これらの遺伝子は動脈硬化症の 潜在的予測バイオマーカーです
さらに関連する動画
18:30RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
22.0K
04:21Author Spotlight: Vascular Tissue Dissociation and Exploring Single-Cell Subclusters for Targeted Therapy
Published on: January 19, 2024
3.0K
関連する概念動画
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
01:18Structure and Function of Platelets
5.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
5.5K
01:22Formation of the Platelet Plug
10.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K